CFLP1: A Potential Drug Target for Various Diseases (G142913)

Target Name: CFL1P1

NCBI ID: G142913

CFL1P1

Other Name(s): CFLP1 | cofilin 1 pseudogene 1 | Cofilin 1 pseudogene 1 | MGC35136

CFLP1: A Potential Drug Target for Various Diseases

CFLP1 (CFLP1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the evolutionarily conserved family of cytoskeletal proteins known as the and Historically Transformed Transcription Factor (HISF) family . CFLP1 is known for its role in the regulation of cellular processes that are essential for the development, maintenance, and function of tissues and organs, including the brain.

Recent studies have identified CFLP1 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is due to CFLP1's involvement in a wide range of cellular processes that are crucial for the normal functioning of tissues, as well as its potential to modulate the activity of other proteins that are involved in disease development.

One of the key mechanisms by which CFLP1 is thought to contribute to disease is its role in the regulation of cell division and the cell cycle. CFLP1 is known to play a role in the metaphase G1 checkpoint, which is a critical step in the cell cycle that ensures that cells have enough copies of their genetic material to divide properly. Meticulous regulation of the cell cycle is essential for the development and maintenance of tissues and organs, and alterations in the cell cycle can contribute to the development of cancer.

In addition to its role in cell division, CFLP1 is also involved in the regulation of cell adhesion and migration. CFLP1 has been shown to play a critical role in the formation of tight junctions, which are a type of cell-cell adhesion that is essential for the proper functioning of tissues such as the skin and the heart. CFLP1 is also involved in the regulation of cell migration, which is critical for the development and maintenance of tissues and organs.

The role of CFLP1 in the regulation of the cell cycle and cell adhesion is also relevant to neurodegenerative diseases, in which the misregulation of cell division and cell cycle can contribute to the development of neurodegeneration. Studies have shown that CFLP1 is involved in the regulation of the cell cycle and cell adhesion in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its role in the regulation of cell division and cell adhesion, CFLP1 is also involved in the regulation of inflammation and immune response. CFLP1 has been shown to play a critical role in the regulation of inflammation and immune response, as well as in the regulation of cellular processes that are essential for the development and maintenance of tissues and organs.

The potential utility of CFLP1 as a drug target is due to its involvement in a wide range of cellular processes that are crucial for the normal functioning of tissues and organs. Its role in the regulation of cell division, cell adhesion, and the cell cycle is also relevant to the development and maintenance of tissues and organs, as well as the regulation of inflammation and immune response. As such, CFLP1 is a promising target for the development of new drugs for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In conclusion, CFLP1 is a protein that is expressed in various tissues throughout the body that is involved in the regulation of a wide range of cellular processes that are essential for the development, maintenance, and function of tissues and organs. Its role in the regulation of cell division, cell adhesion, and the cell cycle, as well as its involvement in the regulation of inflammation and immune response make it a promising target for the development of new drugs for a variety of diseases. Further research is needed to fully understand the role of CFLP1 as a drug target and to identify the most effective strategies for its manipulation for therapeutic benefit.

Protein Name: Cofilin 1 Pseudogene 1

The "CFL1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFL1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets